Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1 von GIACCONE, Giuseppe, HERBST, Roy S, GATZEMEIER, Ulrich, GROUS, John, OCHS, Judith S, AVERBUCH, Steven D, WOLF, Michael K, RENNIE, Pamela, FANDI, Abderrahim, JOHNSON, David H, MANEGOLD, Christian, SCAGLIOTTI, Giorgio, ROSELL, Rafael, MILLER, Vincent, NATALE, Ronald B, SCHILLER, Joan H, VON PAWEL, Joachim, PLUZANSKA, Anna

Volltext

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2 von HERBST, Roy S, GIACCONE, Giuseppe, WOLF, Michael K, KREBS, Annetta D, AVERBUCH, Steven D, OCHS, Judith S, GROUS, John, FANDI, Abderrahim, JOHNSON, David H, SCHILLER, Joan H, NATALE, Ronald B, MILLER, Vincent, MANEGOLD, Christian, SCAGLIOTTI, Giorgio, ROSELL, Rafael, OLIFF, Ira, REEVES, James A

Volltext

The tyrosine kinase inhibitor ZD1839 (iressa) inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells von MOASSER, Mark M, BASSO, Andrea, AVERBUCH, Steven D, RNSEN, Neal

Volltext

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer: A Randomized Trial von Kris, Mark G, Natale, Ronald B, Herbst, Roy S, Lynch, Jr, Thomas J, Prager, Diane, Belani, Chandra P, Schiller, Joan H, Kelly, Karen, Spiridonidis, Harris, Sandler, Alan, Albain, Kathy S, Cella, David, Wolf, Michael K, Averbuch, Steven D, Ochs, Judith J, Kay, Andrea C

Volltext

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer von FUKUOKA, Masahiro, YANO, Seiji, EEK, Richard, HORAI, Takeshi, NODA, Kazumasa, TAKATA, Ichiro, SMIT, Egbert, AVERBUCH, Steven, MACLEOD, Angela, FEYEREISLOVA, Andrea, DONG, Rui-Ping, BASELGA, José, GIACCONE, Giuseppe, TAMURA, Tomohide, NAKAGAWA, Kazuhiko, DOUILLARD, Jean-Yves, NISHIWAKI, Yutaka, VANSTEENKISTE, Johan, KUDOH, Shinzoh, RISCHIN, Danny

Volltext

Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 Is Generally Well-Tolerated and Has Activity in Non–Small-Cell Lung Cancer and Other Solid Tumors:... von HERBST, Roy S, MADDOX, Anne-Marie, OCHS, Judith, MUCCI LORUSSO, Patricia, ROTHENBERG, Mace L, SMALL, Eric J, RUBIN, Eric H, BASELGA, Jose, ROJO, Federico, WAUN KI HONG, SWAISLAND, Helen, AVERBUCH, Steven D

Volltext

Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement von Tsimberidou, Apostolia M, Levit, Laura A, Schilsky, Richard L, Averbuch, Steven D, Chen, Daniel, Kirkwood, John M, McShane, Lisa M, Sharon, Elad, Mileham, Kathryn F, Postow, Michael A

Volltext

Quantifying factors for the success of stratified medicine von Trusheim, Mark R., Burgess, Breon, Hu, Sean Xinghua, Long, Theresa, Averbuch, Steven D., Flynn, Aiden A., Lieftucht, Alfons, Mazumder, Abhijit, Milloy, Judy, Shaw, Peter M., Swank, David, Wang, Jian, Berndt, Ernst R., Goodsaid, Federico, Palmer, Michael C.

Volltext

Why Oncologists Should Care About Climate Change von Schiller, Joan H., Averbuch, Steven D., Berg, Christine D.

Volltext

Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement von Tsimberidou, Apostolia M, Levit, Laura A, Schilsky, Richard L, Averbuch, Steven D, Chen, Daniel, Kirkwood, John M, McShane, Lisa M, Sharon, Elad, Mileham, Kathryn F, Postow, Michael A

Volltext

Making the investigational oncology pipeline more efficient and effective: are we headed in the right direction? von LoRusso, Patricia M, Anderson, Aparna B, Boerner, Scott A, Averbuch, Steven D

Volltext

Translating clinical trials into meaningful outcomes von LoRusso, Patricia M, Schnipper, Lowell E, Stewart, David J, Boerner, Scott A, Averbuch, Steven D, Wolf, Walter

Volltext

Lung cancer prevention: retinoids and the epidermal growth factor receptor-a phoenix rising? von Averbuch, Steven D

Volltext

Improvements in Quality of Life and Disease-related Symptoms in Phase I Trials of the Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 in Non-Small... von LORUSSO, Patricia M, HERBST, Roy S, BJORK, Thomas, MADDOX, Anne-Marie, ROTHENBERG, Mace L, SMALL, Eric J, RUBIN, Eric H, FEYEREISLOVA, Andrea, HEYES, Anne, AVERBUCH, Steven D, OCHS, Judith, BASELGA, José, RISCHIN, Danny, RANSON, Malcolm, CALVERT, Hilary, RAYMOND, Eric, KIEBACK, Dirk, KAYE, Stan, GIANNI, Luca, HARRIS, Adrian

Volltext

Treatment of Malignant Pheochromocytoma/ Paraganglioma With Cyclophosphamide, Vincristine, and Dacarbazine : Recommendation From a 22-Year Follow-up of 18 Patients von HUI HUANG, ABRAHAM, Jame, HUNG, Elizabeth, AVERBUCH, Steven, MERINO, Maria, STEINBERG, Seth M, PACAK, Karel, FOJO, Tito

Volltext

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer von Fukuoka, Masahiro, Yano, Seiji, Giaccone, Giuseppe, Tamura, Tomohide, Nakagawa, Kazuhiko, Douillard, Jean-Yves, Nishiwaki, Yutaka, Vansteenkiste, Johan, Kudoh, Shinzoh, Rischin, Danny, Eek, Richard, Horai, Takeshi, Noda, Kazumasa, Takata, Ichiro, Smit, Egbert, Averbuch, Steven, Macleod, Angela, Feyereislova, Andrea, Dong, Rui-Ping, Baselga, José

Volltext

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer (Reprinted from vol 21, pg 2237-2246, 2003) von Fukuoka, Masahiro, Yano, Seiji, Giaccone, Giuseppe, Tamura, Tomohide, Nakagawa, Kazuhiko, Douillard, Jean-Yves, Nishiwaki, Yutaka, Vansteenkiste, Johan, Kudoh, Shinzoh, Rischin, Danny, Eek, Richard, Horai, Takeshi, Noda, Kazumasa, Takata, Ichiro, Smit, Egbert, Averbuch, Steven, Macleod, Angela, Feyereislova, Andrea, Dong, Rui-Ping, Baselga, Jose

Volltext

Abstract CT212: Expanded phase 1/2a study of PLX8394, a novel next generation BRAF inhibitor in patients with advanced, unresectable solid tumors with alterations in BRAF von Janku, Filip, Sherman, Eric, Yaeger, Rona, Parikh, Aparna, Sullivan, Ryan, Feun, Lynn, Fuente, Macarena De La, Tsai, Frank Yung-Chin, Gordon, Michael, Allen, Carl, Rudoltz, Marc S., Balinski, Kathe, Averbuch, Steven, Vidne, Michael, Tarcic, Gabi

Volltext

Abstract CT143: Pooled analysis of PD-L1 expression across 6 tumor types in the nivolumab clinical program von Krigsfeld, Gabriel, Novotny, James, Oroudjev, Emin, Carnahan, Josette, Zuo, Songlan, Averbuch, Steven D., Burns, Virginia

Volltext

The Impact of Gefitinib on Epidermal Growth Factor Receptor Signaling Pathways in Cancer von Averbuch, Steven D.

Volltext